iData Pharma
Pharmaceutical Consulting Service
A unique look at global Immunology, Cancer, Oncology, Anesthesia, and Vaccines drug markets, to identify sales and growth opportunities, with data-driven intelligence and actionable protocols.
Global Drug Markets
The global pharmaceutical industry is greatly impacted by the introduction of new drugs, patent-expirations, first-to-market strategies and clinical trials like never before. A wholesome examination of the global healthcare industry and the role of pharmaceutical products to alleviate pain and suffering, requires a serious look at forces that cause the ebb and flow of markets in various regions of the world.
Who Can benefit from iData
Pharma Research?”
iData Pharma’s 9-step methodology enables and empowers investors and analysts from small start-ups to pharmaceutical giants to gain full insight into global markets for Immunology, Cancer, Oncology, Anesthesia, and Vaccines, and what makes these markets grow or decline, and how they are affected by the forces of change related to policy, reimbursement, pricing, technology, economy, regulations or demographics.
Epidemiology-Based Research
Provides patient and treatment statistics to understand the causes, distribution, and outcomes of diseases in a given population
Extensive Primary
Research
Market sizing and forecasts based on interviews with industry experts
Deep Data
Segmentation
Breaks down market share, units sold, and annual cost by drug and by patient
Global
Coverage
Coverage for over 65 countries world-wide, at prices you can afford
Scope, Depth and Reach of
iData’s Global Presence
Clients Served
Market Segments
Consulting Projects
Countries Covered
What can you Expect from iData
Pharma Research?
You will find not only revenue forecasts in the iData Pharma custom reports, but also units sold, average selling prices of each drug by geography and market shares of products and manufacturers by country or region. Our custom reports analyse and explain commercial prospects at the global, regional, national and product levels, for each topic. This will empower you to assess opportunities and commercial potentials for your related products and services.
iData Pharma package includes
What Our Clients Say
I love the accuracy of the data and the minimal processing required on our end.
Tela Bio
Mark Sellek
Excellent reports and the ability to dive deeper into OUS markets at our request
Envista
Raoul Correa
Good precision in pinpointing details in a niche market
Panthera Dental
Kyle Steadman
The data is reliable and the team has been very accommodating in meeting our needs and taking constructive feedback to make future reports even more attractive
Stryker
Rick Swaim
Very useful reports. Will recommend iData
Pall / Danaher
Elizabeth Kachavos
Very quick turnaround to supply the report.
Signifier Medical Technologies Ltd
Chief Financial Officer
Great offering in the Endoscopy field.
SCHOTT
Han Nguyen
Useful data, easy experience with the iData team
Fujifilm Medical Systems Europe
Samiran Dey
Great communication. Online access is very useful.
Spine Innovations
Laurie Hausswirth
Pricing is excellent. OUS data is better than DRG/Clarivate Service is good
Cerapedics Inc.
K. Schelble
What Global Pharmaceutical
Markets are Covered?”
iData Pharma – Pharmaceutical Consulting Service specializes in the global research for the following markets
Cancer
Oncology
Immunology
Crohn’s Disease
Psoriasis
Ulcerative Colitis
Rheumatoid Arthritis
Anesthesia
Diabetes
Vaccines
How our clients are using iData Pharma?”
Customization and Bundling
Discounts
Global custom reports are usually extensive, but you might not need an extremely detailed report across every disease, or across every region. Our team will work with you to select the qualitative and quantitative data you need and get you the highest quality and most cost-effective solution that fits your budget and timeline.
Start Growing With iData Today
With an in-depth knowledge of the healthcare industry and a team of consultants, excited to help you, data-driven market intelligence and go-to strategy, is one step away.
